| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5589579 | Gene | 2017 | 44 Pages |
Abstract
Our findings suggest that dysregulations of CDKN2A, IL1R2 and RFC4 may contribute to cervical cancer progression and they might be potential diagnostic markers and therapeutic drug targets.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Guoping Niu, Duping Wang, Yunfeng Pei, Li Sun,